DANIELLE CARR: Open Payments
NPI 1043787013 · BLOOMFIELD HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 43 payments from 15 companies in 2025. Trend: 2023 $1,116 · 2024 $1,171 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $124 |
| Novo Nordisk Inc | 7 | $117 |
| Janssen Pharmaceuticals, Inc | 3 | $96 |
| Axsome Therapeutics, Inc. | 4 | $94 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| PFIZER INC. | 5 | $84 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Lilly USA, LLC | 2 | $29 |
Products named: VRAYLAR, SPRAVATO, Auvelity, AIRSUPRA, Ozempic, AREXVY, JARDIANCE, PREVNAR 20.
Industry payments across MI — which companies pay providers there.
